Page last updated: 2024-10-25

ciprofloxacin and Lymphoproliferative Disorders

ciprofloxacin has been researched along with Lymphoproliferative Disorders in 1 studies

Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.

Lymphoproliferative Disorders: Disorders characterized by proliferation of lymphoid tissue, general or unspecified.

Research Excerpts

ExcerptRelevanceReference
"Twenty-four episodes of fever in neutropenic patients with haematological malignancy were treated with ciprofloxacin."3.67Preliminary evaluation of ciprofloxacin, a new 4-quinolone antibiotic, in the treatment of febrile neutropenic patients. ( Farrell, ID; Geddes, AM; Leyland, MJ; Smith, GM, 1986)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Smith, GM1
Leyland, MJ1
Farrell, ID1
Geddes, AM1

Other Studies

1 other study available for ciprofloxacin and Lymphoproliferative Disorders

ArticleYear
Preliminary evaluation of ciprofloxacin, a new 4-quinolone antibiotic, in the treatment of febrile neutropenic patients.
    The Journal of antimicrobial chemotherapy, 1986, Volume: 18 Suppl D

    Topics: Adult; Aged; Agranulocytosis; Bacterial Infections; Ciprofloxacin; Female; Fever; Half-Life; Humans;

1986